Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted...

Area of Science:

• Hepatology
• Oncology
• Viral Hepatitis Research

Background:

• Hepatocellular carcinoma (HCC) surveillance is recommended semi-annually for patients with cirrhosis.
• Viral hepatitis B or C are common causes of compensated cirrhosis, increasing HCC risk.

Purpose of the Study:

• To investigate the impact of adherence to HCC surveillance guidelines on survival in patients with viral cirrhosis.
• To determine if timely surveillance influences early detection and treatment allocation for HCC.

Main Methods:

• Analysis of the prospective ANRS CO12 CirVir study data (2006-2012).
• Inclusion of 216 patients with viral cirrhosis who developed HCC during follow-up.
• Definition of compliance as <7 months between surveillance image evaluations and HCC diagnosis.

Main Results:

• Patients compliant with surveillance guidelines had significantly longer overall survival (median 53.2 months vs. 25.4 months) after lead-time adjustment.
• Compliance was associated with earlier HCC diagnosis (BCLC stage 0/A), reduced tumor burden, and increased allocation of curative treatments.
• Multivariate analysis confirmed compliance as a significant factor for improved survival (HR 2.19).

Conclusions:

• Adherence to HCC surveillance guidelines is crucial for improving survival in patients with viral cirrhosis.
• Regular surveillance facilitates early HCC detection, enabling curative treatment and better patient outcomes.
• The study highlights the clinical benefit of strict adherence to recommended surveillance intervals.